EGFR Positive UK
Home News Contact
Donate
Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2023/24
What is EGFR? Treatment Options Glossary
EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources
Donating Fundraising
Home About Us Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2023/24 About EGFR What is EGFR? Treatment Options Glossary Patient Support EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources NewsContact Get Involved Donating Fundraising
EGFR Positive UK
Offering hope & learning for those with EGFR+
Donate
 

News

 
news-purple.jpg
EGFR+ UK Members' Survey Results
EGFR+ UK Members' Survey Results
Web TeamJuly 10, 2024 Comment
Research Highlights May 2024
Research Highlights May 2024
Web TeamMay 24, 2024
Tribute to Lizzi Brazier, Secretary & Member Liaison Trustee
Tribute to Lizzi Brazier, Secretary & Member Liaison Trustee
Web TeamMay 24, 2024
EGFR+ UK Thames Walk
EGFR+ UK Thames Walk
Web TeamMay 23, 2024
EGFR+ UK Research Trustee Gini is now a Professor!
EGFR+ UK Research Trustee Gini is now a Professor!
Web TeamApril 29, 2024
EGFR+ UK is now registered for Gift Aid
EGFR+ UK is now registered for Gift Aid
Web TeamApril 26, 2024
Mobocertinib: A Lifeline at Risk
Mobocertinib: A Lifeline at Risk
Web TeamFebruary 6, 2024
EGFR+ UK Highlights the Role of Biomarkers in The House of Commons
EGFR+ UK Highlights the Role of Biomarkers in The House of Commons
Web TeamJanuary 25, 2024
What a Difference a Decade + Makes…
What a Difference a Decade + Makes…
Web TeamJanuary 18, 2024
Lung Cancer Awareness Month
Lung Cancer Awareness Month
Web TeamJanuary 18, 2024
Research Highlights
Research Highlights
Web TeamJanuary 17, 2024
Meet & Chat Update
Meet & Chat Update
Web TeamJanuary 16, 2024
All You Need is Lungs
All You Need is Lungs
EGFR PositiveNovember 1, 2023
Fundraising for EGFR+ UK Just Got Easy!
Fundraising for EGFR+ UK Just Got Easy!
Web TeamNovember 1, 2023
Research Highlights
Research Highlights
EGFR PositiveSeptember 16, 2023
Members forum overview
Members forum overview
EGFR PositiveJanuary 18, 2023
Look behind the scenes at LCNUK
Look behind the scenes at LCNUK
EGFR PositiveAugust 7, 2022
BTOG (British Thoracic Oncology Group) Summer Meeting 2022
BTOG (British Thoracic Oncology Group) Summer Meeting 2022
EGFR PositiveAugust 7, 2022
A New Patient Alliance - ODLC
A New Patient Alliance - ODLC
EGFR PositiveAugust 7, 2022
EGFR Positive publication in Oncology and Therapy journal
EGFR Positive publication in Oncology and Therapy journal
EGFR PositiveMarch 26, 2021
Newer Older

The latest news

News
EGFR+ UK at BTOG!
May 10, 2025
EGFR+ UK at BTOG!
May 10, 2025
Read More →
May 10, 2025
Run the London Marathon for EGFR+ UK - Appy Now!
May 1, 2025
Run the London Marathon for EGFR+ UK - Appy Now!
May 1, 2025
Read More →
May 1, 2025
Thank You to Natasha as She Changes Role
Mar 31, 2025
Thank You to Natasha as She Changes Role
Mar 31, 2025
Read More →
Mar 31, 2025
A New First-Line Option for EGFR+ Lung Cancer
Mar 27, 2025
A New First-Line Option for EGFR+ Lung Cancer
Mar 27, 2025
Read More →
Mar 27, 2025
A Chance Encounter
Mar 1, 2025
A Chance Encounter
Mar 1, 2025
Read More →
Mar 1, 2025
Lung Cancer Awareness Month 2024 Update!
Dec 13, 2024
Lung Cancer Awareness Month 2024 Update!
Dec 13, 2024
Read More →
Dec 13, 2024

EGFR+ UK are proud members of Lung Cancer Europe

 
 

NEW! Follow us on Bluesky 🦋

 
 
View fullsize If you or someone you love has EGFR+ lung cancer, these stats might feel all too familiar: ▪️ Half of those diagnosed are under 60 ▪️ 3 out of 4 only find out at stage 4 ▪️ The majority are women ▪️ 68% have never smoked Because EGFR+ lung cancer p
View fullsize Major news for our EGFR+ lung cancer community. Final results from the global FLAURA2 trial confirm it: adding chemo to osimertinib helps people live longer. This is the first time overall survival data has shown a clear benefit for the combination
View fullsize To help you navigate the challenges of travel 🌎 with lung cancer we’ve created a webpage. “Travelling with Lung Cancer” (link in bio) gives tips on managing medications, booking travel, and securing the right insurance, so you can
View fullsize Important update for people newly diagnosed with advanced EGFR+ lung cancer in England: Osimertinib (a targeted EGFR therapy) can now be started up to 30 days before chemotherapy, if there’s an urgent clinical need. This change applies to fir

Medical Disclaimer

The contents of this website are for informational purposes. The content is NOT a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified professional with any question you have regarding a medical condition. EGFR Positive UK does not endorse any companies, products or opinions that may be mentioned on this website.

 

© 2025 EGFR POSITIVE UK - Charity nº 1189722


PRIVACY POLICY

COOKIE POLICY